Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome
- PMID: 38257971
- PMCID: PMC10820110
- DOI: 10.3390/microorganisms12010145
Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome
Abstract
Invasive fungal infections (IFI) cause morbidity and mortality in children with acute leukemia (AL). We retrospectively collected data on febrile neutropenic episodes (FNE) in AL children (2016-2021) and assessed factors associated with proven/probable IFI. Ninety-three children developed 339 FNE. Seventeen (18.3%) children developed 19 proven/probable IFI (11 yeast; eight molds). The proven/probable yeast IFI rate was 6/52 (11.5%) in children who belong to the high risk for IFI category (HR-IFI-AL: high-risk acute lymphocytic leukemia (ALL), acute myeloid leukemia, relapse); and 5/41 (12.2%) in the non-HR-IFI-AL category (standard/intermediate risk ALL). The proven/probable mold IFI rate was 7/52 (13.5%) in HR-IFI-AL children and 1/41 (2.4%) in the non-HR-IFI-AL category. In the multivariable analysis, underlying genetic syndrome, oral mucositis, and older age were significantly associated with proven/probable IFI, while a longer time since AL diagnosis was protective. Two of 13 (15.4%) HR-IFI-AL children died because of IFI. The elevated risks of proven/probable mold IFI and the associated mortality in HR-IFI-AL children, and high risk of invasive candidiasis in the non-HR-IFI-AL group, emphasize the need for the close monitoring of local epidemiology and the adjustment of practices accordingly.
Keywords: acute leukemia; children; invasive fungal infections; risk factors.
Conflict of interest statement
The authors declare no conflict of interest related to the current study.
References
-
- Groll A.H., Castagnola E., Cesaro S., Dalle J.H., Engelhard D., Hope W., Roilides E., Styczynski J., Warris A., Lehrnbecher T. Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15:e327–e340. doi: 10.1016/S1470-2045(14)70017-8. - DOI - PubMed
-
- Cesaro S., Tridello G., Castagnola E., Calore E., Carraro F., Mariotti I., Colombini A., Perruccio K., Decembrino N., Russo G., et al. Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients. Eur. J. Haematol. 2017;99:240–248. doi: 10.1111/ejh.12910. - DOI - PubMed
-
- Kobayashi R., Hori D., Sano H., Suzuki D., Kishimoto K., Kobayashi K. Risk Factors for Invasive Fungal Infection in Children and Adolescents with Hematologic and Malignant Diseases: A 10-year Analysis in a Single Institute in Japan. Pediatr. Infect. Dis. J. 2018;37:1282–1285. doi: 10.1097/INF.0000000000002010. - DOI - PubMed
-
- Kobayashi R., Kaneda M., Sato T., Ichikawa M., Suzuki D., Ariga T. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: A 10-year analysis at a single institution at Japan. J. Pediatr. Hematol. Oncol. 2008;30:886–890. doi: 10.1097/MPH.0b013e3181864a80. - DOI - PubMed
-
- Lehrnbecher T., Schöning S., Poyer F., Georg J., Becker A., Gordon K., Attarbaschi A., Groll A.H. Incidence and Outcome of Invasive Fungal Diseases in Children with Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study. Front. Microbiol. 2019;10:681. doi: 10.3389/fmicb.2019.00681. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
